The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
Amphenol APH
Clears the common standardAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Amphenol Corporation, together with its subsidiaries, designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally.
read at $152.67
Amphenol holds its Markup at $152.67.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 7 days |
| Price | $152.67 |
| Valuation | 43.87 trailing · 26.14 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.24 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 12% discount to our $170.93 fair value, moderate competitive moat, 58.40% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 58.40% |
| Profit margin | 17.24% |
| Debt to equity | 133.05 |
| Analyst consensus | Buy · 18 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✗ DOES NOT PASS
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is 42.8% of its assets, above the one-third ceiling the screen allows. Against market value it is 10.0%, under the 30% line the market-value standard uses — so that standard clears it. Divergent
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.8% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 43.7% of assets, under the 49% limit. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Tiny plugs keep the world wired yet debt blocks the door
Every connector Amphenol sells sits inside phones, servers and aircraft that cannot run without them. The firm posts 58 percent revenue growth, 17 percent profit margins and 37 percent ROE, yet it still fails our ethical screen on its debt ratio. Analysts love the name and set targets well above the current price, but that does not move our verdict.
We pass because the ethical failure is clear and non-negotiable. Strong returns and a moderate moat do not offset the leverage issue that our screen flags. The 13 percent margin of safety to our fair value looks thin once that red line is crossed.
High growth can mask rising debt until rates or demand turn. A cyclical slowdown in electronics would expose the leverage quickly and leave little room for error. Analysis, not advice.
| Forward P/E | 26.1x cheap for a company growing this fast |
| Trailing P/E | 43.9x expensive — the price assumes strong growth ahead |
| Revenue growth | 58.4% growing very fast |
| Profit margin | 17.2% healthy profit margins |
| Return on equity | 36.8% an exceptional return on shareholder capital |
| Debt to equity | 1.33 a meaningful debt load worth watching |
| Current ratio | 1.71 healthy short-term liquidity |
| Beta | 1.24 moves a little more than the market |
| Market cap | $187.8B |
| Employees | 170,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on APH
- › Amphenol Builds AI Edge Through Strategic Acquisitions: What's Ahead? Zacks · 18h ago
- › WESCO Q2 Earnings Surpass Expectations, Revenues Increase Y/Y Zacks · 18h ago
- › COHU Q2 Earnings Beat Estimates on AI Compute and Favorable Mix Zacks · 21h ago
- › Check Point Q2 Earnings Beat Estimates, Revenues Increase Y/Y Zacks · 23h ago
- › Does Record Q2 Results And AI-Driven Guidance Shift The Bull Case For Amphenol (APH)? Simply Wall St. · 1d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in APH's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
APH trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 63%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (18 analysts) rates it strong buy, with a mean price target of $182.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | NORWITT RICHARD ADAM | Chief Executive Officer | 130,775 | $2,925,764 | |
| 2026-05-05 | NORWITT RICHARD ADAM | Chief Executive Officer | 130,775 | $18,709,066 | |
| 2026-02-18 | D'AMICO LANCE E | General Counsel | 50,000 | $1,127,625 | |
| 2026-02-18 | LAMPO CRAIG A | Chief Financial Officer | 100,000 | $2,199,500 | |
| 2026-02-18 | D'AMICO LANCE E | General Counsel | 50,000 | $7,494,155 | |
| 2026-02-18 | LAMPO CRAIG A | Chief Financial Officer | 100,000 | $14,998,130 | |
| 2026-02-12 | NORWITT RICHARD ADAM | Chief Executive Officer | 608,333 | $13,609,930 | |
| 2026-02-12 | NORWITT RICHARD ADAM | Chief Executive Officer | 608,333 | $89,577,563 | |
| 2026-02-05 | LIVINGSTON ROBERT A | Director | 10,000 | $1,285,080 | |
| 2026-02-04 | IVAS MICHAEL R | Officer | 25,000 | $559,312 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $122.47 | +22.6% | · | $1,226 | +22.6% |
| 2 months | $140.75 | +6.6% | · | $1,066 | +6.6% |
| 3 months | $131.21 | +14.4% | $0.25 | $1,146 | +14.6% |
| 6 months | $138.55 | +8.3% | $0.50 | $1,087 | +8.7% |
| 1 year | $91.84 | +63.4% | $0.83 | $1,643 | +64.3% |
| 2 years | $65.86 | +127.9% | $1.44 | $2,301 | +130.1% |
| 3 years | $38.14 | +293.6% | $1.87 | $3,985 | +298.5% |
| 5 years | $32.69 | +359.1% | $2.62 | $4,671 | +367.1% |
Historical returns from market close data. Past performance does not guarantee future results.